Skip to main content
. 2022 Aug 1;22:981. doi: 10.1186/s12913-022-08360-0

Table 5.

Knowledge of injectable contraceptives retention from posttest to 9 months among CPs and Tier 2 PPMVs (n = 485)

Posttest (n = 485) 9 months later, among those that answered correctly at posttest
Syringe and needle are used to administer Depo-Provera (n = 420)
  Incorrect 12.2 7.9
  Correct 86.6 92.1
Depo-Provera is administered intramuscularly (n = 451)
  Incorrect 7.0 15.7
  Correct 93.0 84.3
Depo-Provera can be administered in buttocks, deltoid, thighs (n = 385)
  Incorrect 20.6 19.5
  Correct 79.4 80.5
Depo-Provera is administered every 3 months (n = 460)
  Incorrect 5.2 3.5
  Correct 94.8 96.5
Uniject is used to administer Sayana Press (n = 429)
  Incorrect 8.7 4.9
  Correct 88.5 95.1
Sayana Press is administered subcutaneously (n = 441)
  Incorrect 9.1 9.3
  Correct 90.9 90.7
Sayana Press can be administered on thighs, abdominal wall, back of the arm (n = 260)
  Incorrect 44.7 48.1
  Correct 53.6 51.9
Sayana Press is administered every 3 months (n = 416)
  Incorrect 14.2 9.6
  Correct 85.8 90.4
Depo Provera/Sayana Press have same active drug (n = 429)
  Incorrect 11.5 4.2
  Correct 88.5 95.8
Sharp box contents disposed at health facility (n = 205)
  Incorrect 57.7 17.6
  Correct 42.3 82.4
Injectables stored at room temperature and out of direct sunlight (n = 448)
  Incorrect 4.7 7.1
  Correct 92.4 92.9